ArticleRSC advances2018
Improving the inhibitory effect of CXCR4 peptide antagonist in tumor metastasis with an acetylated PAMAM dendrimer.
Changliang Liu, Hongyang Duan, Zijian Zhao, Wenzhe Li, Lilusi Ma, Xiaocui Fang, Chen Wang, Yanlian Yang
Erratum issuedOpen access · goldAbstract read
In one paragraphArticle in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
- Erratum issued
- Erratum issued
5 · Who and what moneyAuthors and funding
8 authors at 2 institutions in 3 countries.
Changliang LiuCAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory of Biological Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology Beijing 100190 P. R. China fangxc@nanoctr.cn wangch@nanoctr.cn yangyl@nanoctr.cn +86-10-82545561 +86-10-82545559.ORCID 0000-0002-9905-5428 Hongyang DuanCAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory of Biological Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology Beijing 100190 P. R. China fangxc@nanoctr.cn wangch@nanoctr.cn yangyl@nanoctr.cn +86-10-82545561 +86-10-82545559.ORCID 0000-0002-1840-4682 Zijian ZhaoCAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory of Biological Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology Beijing 100190 P. R. China fangxc@nanoctr.cn wangch@nanoctr.cn yangyl@nanoctr.cn +86-10-82545561 +86-10-82545559.
Wenzhe LiCAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory of Biological Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology Beijing 100190 P. R. China fangxc@nanoctr.cn wangch@nanoctr.cn yangyl@nanoctr.cn +86-10-82545561 +86-10-82545559.
Lilusi MaCAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory of Biological Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology Beijing 100190 P. R. China fangxc@nanoctr.cn wangch@nanoctr.cn yangyl@nanoctr.cn +86-10-82545561 +86-10-82545559.
Xiaocui FangCAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory of Biological Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology Beijing 100190 P. R. China fangxc@nanoctr.cn wangch@nanoctr.cn yangyl@nanoctr.cn +86-10-82545561 +86-10-82545559.
Chen WangCAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory of Biological Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology Beijing 100190 P. R. China fangxc@nanoctr.cn wangch@nanoctr.cn yangyl@nanoctr.cn +86-10-82545561 +86-10-82545559.ORCID 0000-0001-5685-912X Yanlian YangCAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory of Biological Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology Beijing 100190 P. R. China fangxc@nanoctr.cn wangch@nanoctr.cn yangyl@nanoctr.cn +86-10-82545561 +86-10-82545559.
Center for NanoScience · DEPeking University · CN
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
The metastasis of breast cancer is one of the main factors resulting in the high fatality of patients. Although many antagonists have been developed to inhibit the metastasis of breast cancer, their practical application has been limited because of the poor solubility of many chemotherapeutic drugs in the physiological environment. Herein, a complex of E5 peptide antagonist and acetylated PAMAM G5 (P
Identifiers
PMID35558209
PMCPMC9091381
OpenAlexW4244309689
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390